Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF.
Yamada
Akihiro
A
Internal Medicine Department, Toho University Sakura Medical Centre, Chiba, Japan.
Sono
Koji
K
Hosoe
Nobuo
N
Takada
Nobuo
N
Suzuki
Yasuo
Y
D000328:Adult; D000906:Antibodies / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000097:blood / Q000276:immunology* / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000032:analysis; D015331:Cohort Studies; D003424:Crohn Disease / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D005765:Gastrointestinal Agents / Q000097:blood / Q000276:immunology* / Q000627:therapeutic use; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods; D000069285:Infliximab; D008297:Male; D015166:Monitoring, Immunologic / Q000379:methods*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D055815:Young Adult
D000906:Antibodies; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein; D000069285:Infliximab